In this Section |
255313 Going Door-to-Door to Reach At-Risk Women to Promote Breast Cancer Screening on the Westside of ChicagoWednesday, October 31, 2012
: 8:45 AM - 9:00 AM
Poor access to breast cancer screening may be one cause of widening Black-White disparities in breast cancer mortality (RR=1.62, 2005-07). Building on the successes of traditional patient navigation programs, community navigation aims to reach women who are most at-risk where they live. In April-September 2011, Helping Her Live launched a door-to-door (D2D) campaign in an attempt to reach all women residing in our 2 Chicago target communities. Community Health Workers (CHWs) visited each home and spoke with eligible women, attempting to enroll them for help obtaining breast health services. Between April and September 2011, CHWs spent 1,034 hours visiting 3,831 homes, reaching a total of 352 eligible women. Of these, 171 requested help obtaining a mammogram. Thus far, 46 women have completed a mammogram. It thus takes 2.9 D2D hours to generate a request for service and 22.5 D2D hours to generate a completed mammogram (this figure will fall as additional mammograms are completed). Going door-to-door is an effective way to ensure that you are reaching all women in a target area. However, it is time- and resource-intensive and may not be a feasible option for most projects. Additional data to be presented will provide comparisons of this type of outreach with other outreach strategies.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practiceImplementation of health education strategies, interventions and programs Learning Objectives: Keywords: Mammography Screening, Outreach Programs
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I helped implement the outreach strategy discussed and managed the data analysis of the strategy I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 5095.0: Screening: Key to Early Detection and Intervention
|